Vincristine (Pediatric)
A vinca alkaloid that stops cell division. **Warning: For Intravenous use ONLY. Intrathecal administration is fatal.**
Dosage by Body Weight
Pediatric dose: 1.5 mg/m² (for weight >10kg) or 0.05 mg/kg (for weight <10kg). Max dose 2 mg.
- Body Weight
- Below 10 kg
- Dose
- 0.05 mg per kg
- Frequency
- Weekly (Oncology schedule)
- Tracking Notes
- Monitor for constipation and peripheral neuropathy (weakness).
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 10 kg | 0.05 mg per kg | Weekly (Oncology schedule) | Monitor for constipation and peripheral neuropathy (weakness). |
Formulation
Injection
Purpose
Chemotherapy for pediatric cancers including Acute Lymphoblastic Leukemia (ALL) and Wilms tumor.
Generic Name
Vincristine Sulfate
Branded Drug Names
Vincristine (Pediatric) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
- Oncovin
- Vinicrist
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Vinblastine